Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 474 M450 M471 M494 M458 M460 M 1.88 B Research & development —————— — Operating income 214 M168 M169 M143 M288 M264 M 864 M Non-Operating Income, Total 273 M-144 M-261 M20 M082 M -159 M Interest expense, net of interest capitalized 43 M44 M45 M45 M46 M44 M 180 M Non-Operating Income, excl. Interest Expenses 77 M-124 M-169 M-31 M-49 M0 -249 M Unusual income/expense 153 M-64 M-137 M6 M3 M38 M -90 M Pretax income 330 M65 M-11 M106 M246 M254 M 595 M Equity in earnings —————— — Taxes 89 M29 M5 M-3 M71 M73 M 146 M Non-controlling/minority interest 5 M000-1 M-2 M -3 M After tax other income/expense —————— — Net income before discontinued operations 236 M36 M-16 M109 M176 M183 M 452 M Discontinued operations —————— — Net income 236 M36 M-16 M109 M176 M183 M 452 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 233 M36 M-16 M108 M172 M179 M 443 M Basic earnings per share (Basic EPS) 0.450.07-0.030.20.330.35 0.85 Diluted earnings per share (Diluted EPS) 0.450.07-0.030.20.330.34 0.84 Average basic shares outstanding 143.05 M144 M144.62 M145.13 M146.75 M146.66 M — Diluted shares outstanding 143.05 M144 M144.62 M145.13 M146.75 M149.41 M — EBITDA 300 M258 M265 M247 M392 M367 M 1.27 B EBIT 214 M168 M169 M143 M293 M264 M 869 M Cost of revenue 894 M791 M913 M1.03 B987 M930 M 3.86 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 86 M90 M96 M104 M99 M103 M 402 M